Group Visits for High Risk Type 1 Diabetes (T1D)

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
Children's National Research Institute
Study ID
NCT05431686
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
8 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • SMA visits — BEHAVIORAL
    SMA visit once every 3 months over a 12 month period

Study Details

The investigators propose to conduct a pilot prospective cohort study to assess the impact of shared medical appointments (SMA) visits in underserved youth with poorly controlled type 1 diabetes (T1D). The trial will employ an enrollment visit, SMA visits every 3 months over a 12 month study period, followed by a 6-month observational period to assess feasibility and acceptability of SMA and the impact on glycemic control, self-management skills, and health related quality of life.

Key Dates

Start date
Feb 16, 2022
Status verified
Dec 2025
Primary completion
Jul 1, 2025
Completion
Jul 1, 2025

Study Design

Enrollment
14 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: SMA visit intervention arm
    SMAs will occur once every 3 months, and consist of 4-6 underserved youth with T1D and their primary diabetes caregiver

Primary Outcome Measure

Percentage of Eligible Participants Who Agreed to Participate as Assessed by Tracking Those Who Were Approached to Participate and Those Who Agreed to Participate [ Time Frame: 12 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Children's National HospitalWashington D.C.District of Columbia20010-

Find similar trials in Washington D.C., DC

By condition
Type 1 diabetes
By specialty
Endocrinology
By research site
Children's National Hospital· Washington D.C., DC

Related Studies